Oramed Pharmaceuticals Inc. (ORMP)

Oramed Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Aug 31, 2021	Aug 31, 2020	Aug 31, 2019
Market Capitalization	104	93	471	640	82	58
Market Cap Growth	36.42%	-80.20%	-26.46%	679.31%	42.27%	-32.85%
Enterprise Value	-40	-17	316	546	42	25
PE Ratio	9.81	16.87	-12.87	-28.77	-7.13	-4.02
PS Ratio	153.71	69.54	174.08	236.73	30.30	21.35
PB Ratio	0.62	0.57	3.10	5.53	2.50	2.98
P/FCF Ratio	-18.84	-8.83	-16.57	-29.68	-6.56	-4.45
P/OCF Ratio	-19.02	-9.05	-16.85	-30.21	-6.60	-4.46
EV/Sales Ratio	-38.16	-12.87	116.81	202.10	15.60	9.41
EV/EBITDA Ratio	-2.62	-2.22	-8.67	-24.66	-3.82	-1.88
EV/EBIT Ratio	-2.68	-2.28	-8.66	-24.57	-3.82	-1.87
EV/FCF Ratio	4.10	1.63	-11.12	-25.34	-3.38	-1.96
Debt / Equity Ratio	0.20	0.32	0.01	0.00	0.00	-
Debt / EBITDA Ratio	3.32	6.65	-0.02	-0.02	-0.01	-
Debt / FCF Ratio	-5.19	-4.89	-0.03	-0.02	-0.01	-
Quick Ratio	5.26	3.05	27.10	14.09	8.80	6.08
Current Ratio	5.28	3.06	27.34	14.27	8.93	6.28
Asset Turnover	0.00	0.01	0.02	0.03	0.07	0.07
Interest Coverage	-	3.71	-	-2778.75	-24.93	-27.98
Return on Equity (ROE)	6.60%	3.60%	-23.50%	-29.90%	-45.90%	-60.30%
Return on Assets (ROA)	5.20%	2.90%	-22.10%	-25.80%	-30.30%	-36.50%
Return on Capital (ROIC)	-6.79%	-7.32%	-26.59%	-20.83%	-35.68%	-75.44%
Earnings Yield	10.09%	5.93%	-7.77%	-3.48%	-14.02%	-24.87%
FCF Yield	-6.06%	-11.32%	-6.03%	-3.37%	-15.25%	-22.45%
Buyback Yield / Dilution	-3.80%	-4.02%	-36.98%	-38.65%	-17.63%	-17.28%
Total Shareholder Return	-3.80%	-4.02%	-36.98%	-38.65%	-17.63%	-17.28%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).